High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers.
about
HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.Gene isoforms as expression-based biomarkers predictive of drug response in vitro.Although it's painful: The importance of stringent antibody validation.Mangiferin inhibits cell migration and invasion through Rac1/WAVE2 signalling in breast cancer.CTBP1 and metabolic syndrome induce an mRNA and miRNA expression profile critical for breast cancer progression and metastasis.
P2860
High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
High expression of integrin β6 ...... HER2 amplified breast cancers.
@en
type
label
High expression of integrin β6 ...... HER2 amplified breast cancers.
@en
prefLabel
High expression of integrin β6 ...... HER2 amplified breast cancers.
@en
P2093
P2860
P356
P1433
P1476
High expression of integrin β6 ...... HER2 amplified breast cancers
@en
P2093
Annie Alexander
Anupama Vinod
Aruna Korlimarla
B S Srinath
Geetashree Mukherjee
Jyothi S Prabhu
K S Gopinath
Krisha Desai
M S N Prasad
Madhumathy G Nair
P2860
P304
P356
10.1002/CAM4.756
P407
P577
2016-05-17T00:00:00Z